Smart pumps may prevent dangerous drops in blood pressure during drug swaps
NCT ID NCT01127152
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using automatic pumps to switch syringes of noradrenalin (a drug that raises blood pressure) reduces the risk of hypotension compared to manual swaps. Fifty intensive care patients receiving noradrenalin were monitored. The goal was to see if automatic relays cut the number of blood pressure drops by half.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- noradrenalin
- What this could lead to
- If automatic relays reduce hypotension, this could lead to safer drug delivery in intensive care.
- What could go wrong
- This is a small, completed study with only 50 participants, so results may not apply broadly. The benefit may be small or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Start date
-
Jun 2009
- Finished
-
Apr 2011
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient \> 18 years, * Patient receiving only noradrenalin as catecholamine, * Collection of patient's non-objection or his trustworthy person, if appropriate. Exclusion Criteria: * Pregnant or breast feeding patient, * Patient receiving an other treatment on the catecholamine way, * No affiliation at a social security, * Refusal of patient's trustworthy person or parent, if the patient is unable to give his non-objection. * Refusal of patient's participation when he is conscious, * Subjects deprived of liberty, under guardianship, hospitalized in a health facility or social or hospitalized without their consent, * Patients with secreting tumor, kind pheochromocytoma ou carcinoid tumor.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypotension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHD Vendée
La Roche-sur-Yon, Vendée, 85925, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a slower oxytocin infusion prevent dangerous blood pressure drops in C-Sections?
- Spinal stimulation may tame blood pressure swings after injury
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a Light-Guided device make arterial sticks easier?
- Can a simple pill stabilize blood pressure after spinal cord injury?
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?